Clinical Trial Update: Selinexor and Lenalidomide for Consolidation and Maintenance Treatment in Multiple Myeloma Post-transplant [Phase 2]

View source ↗

Summary

This update reports the withdrawal of a Phase 2 trial evaluating selinexor plus lenalidomide as consolidation and maintenance after stem cell transplant in mult…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Myeloma-associated Amyloidosis

Drugs mentioned

• Lenalidomide (lenalidomide)
• Selinexor (selinexor)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Multiple Myeloma, Myeloma-Associated Amyloidosis | Phase 2 | Status: WITHDRAWN